Day: January 7, 2022

US Energy Initiatives Has Placed Orders For Its Mining Equipment

Written by Customer Service on January 7, 2022. Posted in Public Companies.

WOODLAND HILLS, CA, Jan. 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — US Energy Initiatives Corp, Inc. (OTC PINK:USEI) announces that Management has put in orders for its green energy mining initiative, continuing to execute its business plan. According to Anthony K. Miller, CEO, “Today, we announce that USEI currently has a standing order for a number of L3+ miners Bitmain Antminers. These miners have the ability to mine numerous script algorithm coins and tokens, diversifying USEI’s coin holdings and increasing its potential to maximize profitability. USEI’s use of renewable green energy will also give USEI the ability to increase its level of profitability one step further. The focus for renewable energy will remain with solar power as its main source of energy. The use of renewable energy solves the issue that...

ProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel Discussion: Aduhelm Stimulating the Next Generation of Alzheimer’s Treatment

Written by Customer Service on January 7, 2022. Posted in Public Companies.

TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the Biotech Showcase 2022 virtual panel discussion to be held on Jan. 11, 2022 from 8 AM to 9 AM PST. Eugene Williams, ProMIS Chairman and CEO, will participate on the panel, moderated by John Vandermosten, Senior Biotechnology Analyst, Zacks Investment Research. Other panelists include:Phyllis Barkman Ferrell, Global Head of External Engagement for Alzheimer’s disease & Neurodegeneration, Eli Lilly & Company Travis Bond, CEO, Altoida, Inc. Michael McFadden,...

Form 8.3 – [M&C Saatchi plc – 06 01 2022 – Opening Declaration] – (HHL)

Written by Customer Service on January 7, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: HARGREAVE HALE LIMITED (for Discretionary Clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree M&C SAATCHI PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – M&C Saatchi

Written by Customer Service on January 7, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Investec Wealth & Investment Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeM&C Saatchi Plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:Exempt...

Delisting of AS “Olainfarm” shares from the Baltic Main list

Written by Customer Service on January 7, 2022. Posted in Public Companies.

Delisting of AS “Olainfarm” shares from the Baltic Main list With this AS “Olainfarm” informs, that Nasdaq Riga decided on January 7, 2022 to approve the application of AS “Olainfarm” and to delist its shares (ISIN LV0000100501, Ticker OLF1R) from the Baltic Main List. The last listing day of AS “Olainfarm” is set to January 10, 2022. Additional information: Jānis LeimanisJSC Olainfarm Member of the Management BoardTel. +371 29269424E-pasts: janis.leimanis@olainfarm.com

Auction result of Treasury Bonds – RIKB 24 0415 – RIKS 26 0216

Written by Customer Service on January 7, 2022. Posted in Public Companies.

Series RIKB 24 0415 RIKS 26 0216Settlement Date 01/12/2022 01/12/2022Total Amount Allocated (MM) 3,970 2,040All Bids Awarded At (Price / Yield) 97.419 / 3.710 106.500 / -0.084Total Number of Bids Received 15 11Total Amount of All Bids Received (MM) 5,070 2,240Total Number of Successful Bids 12 9Number of Bids Allocated in Full 12 9Lowest Price / Highest Yield Allocated 97.419 / 3.710 106.500 / -0.084Highest Price / Lowest Yield Allocated 97.580 / 3.630 106.655 / -0.120Lowest Price / Highest Yield Allocated in Full 97.419 / 3.710 106.500 / -0.084Weighted Average of Successful Bids (Price/Yield) 97.464 / 3.690 106.550 / -0.095Best Bid (Price / Yield) 97.580 / 3.630 106.655 / -0.120Worst Bid (Price / Yield) 97.378 / 3.730 106.400 / -0.060Weighted Average of All Bids Received (Price...

At 19.4% CAGR, Genomics Market Size [2022-2028] is Projected to Reach USD 94.65 Billion

Written by Customer Service on January 7, 2022. Posted in Mergers And Acquisitions.

Key Players Covered in the Genomics Market Research Report are Illumina, Inc. (California, U.S.), Thermo Fisher Scientific Inc. (Massachusetts, United States), Pacific Biosciences of California, Inc. (California, U.S.), F. Hoffmann-La Roche Ltd. (Basel, Switzerland), Agilent Technologies, Inc. (California, U.S.), Oxford Nanopore Technologies (England, U.K.), Danaher (Washington, D.C., U.S.), QIAGEN (Hilden, Germany), BGI (Guangdong, China), IntegraGen (Evry, France), General Electric Company (Illinois, U.S.) and other key market players Pune, India, Jan. 07, 2022 (GLOBE NEWSWIRE) — The global genomics market size was USD 23.11 billion in 2020. The market is projected to grow from USD 27.81 billion in 2021 to USD 94.65 billion in 2028 at a CAGR of 19.4% in the 2021-2028 period. Based on the research conducted by our analysts, the...

Virbac : Declaration of the number of shares and voting rights 12/2021

Written by Customer Service on January 7, 2022. Posted in Public Companies.

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577 Date Total number of shares representing the share capital Total number of voting rightsDecember, 31 2021 8 458 000 Gross total of voting rights : 12 761 911Net total* of voting rights : 12 752 454 Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights. VIRBAC: Shaping the future of animal health NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP Corporate Finance:...

Monthly disclosure on share capital and voting rights December 31, 2021

Written by Customer Service on January 7, 2022. Posted in Public Companies.

Regulated informationIssy-les-Moulineaux, January 7, 2022 Monthly disclosure on share capital and voting rightsPursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorités des Marchés Financiers Registered name of the issuer: SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUXDate Total number of shares Actual voting rights * Theoretical voting rights ** December 31, 2021 147,454,887 216,466,087 217,556,583 * Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights.** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having...

Mayfair Gold Grants Incentive Stock Options

Written by Customer Service on January 7, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Jan. 07, 2022 (GLOBE NEWSWIRE) — Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) announces the granting of incentive stock options to certain directors, officers, employees of the Company pursuant to the Company’s long-term incentive plan. Options have been granted for an aggregate of 1,855,000 common shares in the capital of the Company at an exercise price of $0.90. The Options are exercisable for a ten-year term expiring January 6, 2032. About Mayfair Mayfair is a Canadian mineral exploration company focused on advancing the 100%-owned Fenn-Gib gold project in the Timmins region of Northern Ontario. The Fenn-Gib gold deposit is Mayfair’s flagship asset. An updated open-pit constrained NI 43-101 resource estimate (February 5, 2021) reported a total Indicated Resource of...

Day: January 7, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals